Large B-Cell Lymphoma With IRF4 Rearrangement
specificA large B-cell lymphoma that usually affects the Waldeyer ring and/or cervical lymph nodes and less often the gastrointestinal tract. It occurs most commonly in children and young adults and is low stage. It is characterized by a follicular, follicular and diffuse, or pure diffuse growth pattern resembling follicular lymphoma grade 3B or a diffuse large B-cell lymphoma. Most cases have IG/IRF4 rearrangements. BCL2 rearrangements are not present. Some cases that belong in this category lack an IR
14
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Large B-Cell Lymphoma With IRF4 Rearrangement(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL High-Volume Research Center | 74.5 |
| 2 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 52.0 |
| 3 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 52.0 |
| 4 | NCI Comprehensive Active Research Program | 52.0 |
| 5 | NCI Comprehensive Active Research Program | 52.0 |
| 6 | NCI Comprehensive Active Research Program | 52.0 |
| 7 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 52.0 |
| 8 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 52.0 |
| 9 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 52.0 |
| 10 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 52.0 |
| 11 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 52.0 |
| 12 | University of Illinois Cancer CenterChicago, IL Active Research Program | 52.0 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 52.0 |
| 14 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 52.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →